prostaglandin A1; PGA1; 14152-28-4; Prosta-10,13-dien-1-oic acid, 15-hydroxy-9-oxo-, (13E,15S)-; PGA1 (Prostaglandin A1); 15a-Hydroxy-9-oxo-10,13E-prostadienoate; VYR271N44P; (13E,15S)-15-hydroxy-9-oxoprosta-10,13-dien-1-oic acid; CHEBI:15545; 15a-Hydroxy-9-oxo-10,13E-prostadienoic acid; 7-[(1R,2S)-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopent-3-en-1-yl]heptanoic acid; 9-oxo-15S-hydroxy-10Z,13E-prostadienoic acid; PGA(sub 1); PGA(sup 1); Prostaglandin A(sub 1); Prostaglandin A(sup 1); Prostaglandin E1-217; Prostaglandin E(sup 1)-217; CHEMBL1084644; UNII-VYR271N44P; 3-Cyclopentene-1-heptanoic acid, 2-(3-hydroxy-1-octenyl)-5-oxo-; Prostaglandin A1, synthetic; BSPBio_001458; BML1-F01; SCHEMBL6417548; Eicosanoids_PGA1_C20H32O4; PGA1, Prostaglandin A1, powder; PROSTAGLANDIN A1 (PGA1); DTXSID601347314; HMS1361I20; HMS1791I20; HMS1989I20; HMS3402I20; HMS3648A03; PROSTAGLANDIN A1 [USP-RS]; (13E,15S)-15-hydroxy-9-oxo-Prosta-10,13-dien-1-oic acid; ZINC4096507; LMFA03010005; CCG-208253; IDI1_033928; NCGC00161282-01; NCGC00161282-02; NCGC00161282-03; 15-hydroxy-9-oxoprosta-10,13-dienoate; 15a-Hydroxy-9-ketoprosta-10,13-dienoate; 15-hydroxy-9-oxoprosta-10,13-dienoic acid; ALPROSTADIL IMPURITY A [EP IMPURITY]; 15a-Hydroxy-9-ketoprosta-10,13-dienoic acid; SR-01000946186; J-007508; SR-01000946186-1; BRD-K04010869-001-02-6; Q27098093; (13E,15S)-15-hydroxy-9-oxo-Prosta-10,13-dien-1-oate; 9-OXO-15S-HYDROXY-PROSTA-10,13E-DIEN-1-OIC ACID; 2-(3-hydroxy-1-octenyl)-5-oxo-3- cyclopentene-1-heptanoate; 2-(3-hydroxy-1-octenyl)-5-oxo-3-Cyclopentene-1-heptanoate; 2-(3-hydroxy-1-octenyl)-5-oxo-3- cyclopentene-1-heptanoic acid; 2-(3-hydroxy-1-octenyl)-5-oxo-3-Cyclopentene-1-heptanoic acid; PGA1 (Prostaglandin A1) is known as a Cyclopentenone prostaglandin.; Prostaglandin A1, United States Pharmacopeia (USP) Reference Standard; 7-((1R,2S)-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopent-3-enyl)heptanoic acid; 7-[(1R,2S)-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-cyclopent-3-en-1-yl]heptanoic acid